<DOC>
	<DOCNO>NCT03020888</DOCNO>
	<brief_summary>The purpose post-marketing study provide prospective evidence Magseed SentimagÂ® effective lesion localization patient undergoing surgical excision breast lesion summarize measure product safety performance .</brief_summary>
	<brief_title>Magseed Magnetic Marker Localization</brief_title>
	<detailed_description>This post-market , prospective , open label , single arm study Magseed Sentimag patient undergo surgical excision breast lesion . Subjects Magseed marker deploy image guidance thirty day prior surgery . The Magseed marker localize use Sentimag system surgery remove lesion . After lumpectomy procedure , subject evaluate safety patient report outcome .</detailed_description>
	<mesh_term>Breast Diseases</mesh_term>
	<criteria>Subjects breast lesion require imageguided localization prior excision . Subjects age 18 year time consent . The subject pregnant lactating . Subject pacemaker implantable device chest wall . Subject current active infection implantation site breast ( per investigatordiscretion )</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>